Edward Kim
Chief Tech/Sci/R&D Officer presso OREXO AB
Profilo
Edward Kim is currently the Chief Medical Officer at Orexo AB since 2022.
Prior to this, he worked as the Vice Chairman-Clinical Services at Robert Wood Johnson Medical School and as the Vice President & Head-Medical Affairs at Biohaven Pharmaceutical Holding Co. Ltd.
Dr. Kim completed his undergraduate degree at Harvard University and his doctorate at Sidney Kimmel Medical College.
Posizioni attive di Edward Kim
| Società | Posizione | Inizio |
|---|---|---|
| OREXO AB | Chief Tech/Sci/R&D Officer | 26/10/2022 |
Precedenti posizioni note di Edward Kim
| Società | Posizione | Fine |
|---|---|---|
| Robert Wood Johnson Medical School | Corporate Officer/Principal | - |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | - |
Formazione di Edward Kim
| Harvard University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OREXO AB | Health Technology |
| Aziende private | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Edward Kim
